Lista de obras - Ettore C degli Uberti - Dominio Público Uruguay

A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization ⬇️

artículo científico publicado el 1 de noviembre de 2010

Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone

artículo científico publicado en 2003

Androgen influences transforming growth factor-beta1 gene expression in human adrenocortical cells

artículo científico publicado en 2000

Antiproliferative effects of somatostatin analogs in pituitary adenomas

artículo científico publicado en 2006

Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study

artículo científico publicado en 2008

Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group ⬇️

artículo científico publicado el 1 de enero de 2011

Atrial natriuretic peptide and circadian blood pressure regulation: clues from a chronobiological approach.

artículo científico publicado en 1993

Atrial strain is the main determinant of release of atrial natriuretic peptide

scientific article published on 01 December 1990

BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies.

artículo científico publicado en 2009

Blood growth hormone-binding protein levels in premenopausal and postmenopausal women: roles of body weight and estrogen levels

artículo científico publicado en 2001

CYP11B2 -344T/C gene polymorphism and blood pressure in patients with acromegaly

artículo científico publicado en 2006

Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion

artículo científico publicado en 2013

Cardiac and metabolic effects of chronic growth hormone and insulin-like growth factor I excess in young adults with pituitary gigantism

artículo científico publicado en 2005

Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study

article

Clinical Value of Different Responses of Serum Thyroglobulin to Recombinant Human Thyrotropin in the Follow-Up of Patients with Differentiated Thyroid Carcinoma

article

Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients

artículo científico publicado en 2006

Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma

artículo científico publicado en 2005

Consistent changes in the circadian rhythms of blood pressure and atrial natriuretic peptide in congestive heart failure

artículo científico publicado en 1991

Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds

artículo científico publicado en 2007

Correction to: Pegvisomant in acromegaly: an update.

artículo científico publicado en 2017

Corticotropin releasing hormone: a diagnostic marker for behavioral and reproductive disorders?

artículo científico publicado en 2007

Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study

artículo científico publicado en 2002

Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-kappaB.

artículo científico publicado en 2009

Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression

artículo científico publicado en 2007

Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism

artículo científico publicado en 2005

Defective hypothalamic growth hormone (GH)-releasing hormone activity may contribute to declining GH secretion with age in man.

artículo científico publicado en 1997

Deletion of exons 1–3 of the MEN1 gene in a large Italian family causes the loss of menin expression

article

Dermorphin decreases plasma LH levels in human: Evidence for a modulatory role of gonadal steroids

artículo científico publicado en 1985

Dermorphin inhibits spinal nociceptive flexion reflex in humans

artículo científico publicado en 1986

Different levels of thyroglobulin mRNA in normal and neoplastic human thyroids

artículo científico publicado en 1986

Differential effects of deltorphin on arginine and galanin-induced growth hormone secretion in healthy man

artículo científico publicado en 1995

Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro.

artículo científico publicado en 2005

Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women.

artículo científico publicado en 1998

Effect of deltorphin on behavior and hippocampal electrical activity in rabbits

artículo científico publicado en 1993

Effect of dermorphin on behavior and hippocampal electrical activity in rabbits.

artículo científico publicado en 1993

Effect of everolimus on cell viability in nonfunctioning pituitary adenomas.

artículo científico publicado en 2009

Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy.

artículo científico publicado en 2011

Efficacy and safety of the new 60-mg formulation of the long-acting somatostatin analog lanreotide in the treatment of acromegaly

artículo científico publicado en 2002

Efficacy of a slow-release formulation of lanreotide (Autogel) 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study

artículo científico publicado en 2007

Evaluation of hormonal function in a series of incidentally discovered adrenal masses.

artículo científico publicado en 1997

Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids.

artículo científico publicado en 2010

Evidence for Differential Effects of Selective Somatostatin Receptor Subtype Agonists on α-Subunit and Chromogranin A Secretion and on Cell Viability in Human Nonfunctioning Pituitary Adenomasin Vitro

artículo científico publicado en 2004

Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation

artículo científico publicado en 2002

Evidence that enhancement of cholinergic tone increases basal plasma levels of calcitonin gene-related peptide in normal man

artículo científico publicado en 1994

Expression of functional KISS1 and KISS1R system is altered in human pituitary adenomas: evidence for apoptotic action of kisspeptin-10

artículo científico publicado en 2010

Growth hormone excess promotes breast cancer chemoresistance

artículo científico publicado en 2009

Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression

artículo científico publicado en 2012

Growth hormone values after an oral glucose load do not add clinically useful information in patients with acromegaly on long-term somatostatin receptor ligand treatment

artículo científico publicado en 2013

High prevalence of differentiated thyroid carcinoma in acromegaly

artículo científico publicado en 2005

High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial.

artículo científico publicado en 2009

Hormonal replacement therapy affects calcitonin gene-related peptide and atrial natriuretic peptide secretion in postmenopausal women.

artículo científico publicado en 1997

Hypopituitarism after traumatic brain injury

artículo científico publicado en 2005

Identification of a c-myc oncogene lacking the exon 1 in the normal cells of a patient carrying a thyroid carcinoma

artículo científico publicado en 1986

Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas

artículo científico publicado en 2007

In vitro effects of estrogen on tgb and c-myc gene expression in normal and neoplastic human thyroids

artículo científico publicado en 1989

In vitro testing of new somatostatin analogs on pituitary tumor cells

artículo científico publicado en 2007

Inhibitory effects of mitotane on viability and secretory activity in mouse gonadotroph cell lines

artículo científico publicado en 2014

Interrelationships between calcitonin gene-related peptide and sympathoadrenomedullary system: Effects of administration of epinephrine and norepinephrine in healthy man

article

Isolated R171Q amino acid change in MEN1 gene: polymorphism or mutation?

artículo científico publicado en 2008

Magmas, a gene newly identified as overexpressed in human and mouse ACTH-secreting pituitary adenomas, protects pituitary cells from apoptotic stimuli

scientific journal article

Maternal plasma calcitonin gene–related peptide levels do not change during labor and are not influenced by delivery route

artículo científico publicado en 2001

MicroRNAs and possible role in pituitary adenoma.

artículo científico publicado en 2008

Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells

artículo científico publicado en 2014

Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function

artículo científico publicado en 2013

Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes

artículo científico publicado en 2010

Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes

scholarly article by Cristina Romei et al published December 2010 in European Journal of Endocrinology

N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis

artículo científico publicado en 2014

Occurrence of pituitary dysfunction following traumatic brain injury

artículo científico publicado en 2004

Ovarian tumors secreting insulin

artículo científico publicado en 2015

Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion

scientific article published on 01 March 2007

Pegvisomant in acromegaly: an update

artículo científico publicado en 2017

Pegvisomant in acromegaly: why, when, how.

artículo científico publicado en 2007

Pitfalls in scintigraphic detection of neuroendocrine tumours

artículo científico publicado en 1992

Pituitary side effects of old and new drugs

artículo científico publicado en 2014

Plasma galanin response to head-up tilt in normal subjects and patients with recurrent vasovagal syncope

artículo científico publicado en 2003

Predictive value of circulating insulin-like growth factor I levels in ischemic stroke outcome

artículo científico publicado en 2006

Predictors of pituitary dysfunction in patients surviving ischemic stroke

artículo científico publicado en 2010

Primary empty sella: Why and when to investigate hypothalamic-pituitary function

artículo científico publicado en 2010

Prognostic Significance of the Ki-67 Labeling Index in Growth Hormone-Secreting Pituitary Adenomas

artículo científico publicado en 2008

Progressive disruption of the circadian rhythm of melatonin in fatal familial insomnia

artículo científico publicado en 1994

Prolactin and growth hormone responses to dermorphin in patients with prolactin-secreting pituitary adenoma

artículo científico publicado en 1985

Prolactin releasing and luteinizing hormone inhibiting activity of dermorphin shorter homologues in the rat

scientific article published on 01 May 1985

Protein kinase C: a putative new target for the control of human medullary thyroid carcinoma cell proliferation in vitro

artículo científico publicado en 2012

RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease.

artículo científico publicado en 2002

Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow-up.

artículo científico publicado en 2014

Rare diseases in clinical endocrinology: a taxonomic classification system.

artículo científico publicado en 2014

Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer

artículo científico publicado en 2014

Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study

artículo científico publicado en 2005

Retinoic acid-induced decrease of DNA synthesis and peroxidase mRNA levels in human thyroid cells expressing retinoic acid receptor alpha mRNA.

artículo científico publicado en 1993

Risk factors for development of atypical femoral fractures in patients on long-term oral bisphosphonate therapy

artículo científico publicado en 2013

Role of complex cyclin d1/cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro.

artículo científico publicado en 2006

Role of pituitary tumour transforming gene 1 in medullary thyroid carcinoma

artículo científico publicado en 2010

Role of transforming growth factor beta 1 (TGF beta 1) in mediating androgen-induced growth inhibition in human adrenal cortex in vitro

artículo científico publicado en 1998

Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study

artículo científico publicado en 2012

SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma.

artículo científico publicado en 2005

Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives.

artículo científico publicado en 2006

Should aip gene screening be recommended in family members of FIPA patients with R16H variant?

artículo científico publicado en 2013

Somatostatin analogs in vitro effects in a growth hormone-releasing hormone-secreting bronchial carcinoid

artículo científico publicado en 2005

Somatostatin receptor subtype 1-selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line

artículo científico publicado en 2002

Somatostatin receptors: from basic science to clinical approach--thyroid.

artículo científico publicado en 2004

Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT.

artículo científico publicado en 2002

Stimulation of growth hormone and corticotropin release by angiotensin II in man

scientific article published on 01 October 1990

Synthetic tetrapeptides related to dermorphin: potent long lasting analgesic action following subcutaneous administration.

artículo científico publicado en 1985

Systemic illness

artículo científico publicado en 2008

Targeting protein kinase C by Enzastaurin restrains proliferation and secretion in human pancreatic endocrine tumors.

artículo científico publicado en 2011

The effects of dermorphin on the endocrine system in man.

artículo científico publicado en 1985

The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells

artículo científico publicado en 2015

Therapeutic concentrations of mitotane (o,p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model

artículo científico publicado en 2010

Thyroid papillary microcarcinoma: a descriptive and meta-analysis study

artículo científico publicado en 2008

Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure*

artículo científico publicado en 1995

Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury

artículo científico publicado en 2004

Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion

artículo científico publicado en 1998

Use of preoperative lymphoscintigraphy and intraoperative gamma-probe detection for identification of the sentinel lymph node in patients with papillary thyroid carcinoma

scientific article published on 06 March 2007

Utilization of luminescent technology to develop a kinase assay: Cdk4 as a model system

artículo científico publicado en 2005

Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto's thyroiditis

artículo científico publicado en 2012

mTOR, p70S6K, AKT, and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids.

artículo científico publicado en 2013

miR-15a and miR-16-1 down-regulation in pituitary adenomas

artículo científico publicado en 2005

miR-26a plays an important role in cell cycle regulation in ACTH-secreting pituitary adenomas by modulating protein kinase Cδ.

artículo científico publicado en 2013

Lista de obras de Ettore C degli Uberti

A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization ⬇️

Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone

Androgen influences transforming growth factor-beta1 gene expression in human adrenocortical cells

Antiproliferative effects of somatostatin analogs in pituitary adenomas

Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study

Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group ⬇️

Atrial natriuretic peptide and circadian blood pressure regulation: clues from a chronobiological approach.

Atrial strain is the main determinant of release of atrial natriuretic peptide

BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies.

Blood growth hormone-binding protein levels in premenopausal and postmenopausal women: roles of body weight and estrogen levels

CYP11B2 -344T/C gene polymorphism and blood pressure in patients with acromegaly

Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion

Cardiac and metabolic effects of chronic growth hormone and insulin-like growth factor I excess in young adults with pituitary gigantism

Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study

Clinical Value of Different Responses of Serum Thyroglobulin to Recombinant Human Thyrotropin in the Follow-Up of Patients with Differentiated Thyroid Carcinoma

Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients

Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma

Consistent changes in the circadian rhythms of blood pressure and atrial natriuretic peptide in congestive heart failure

Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds

Correction to: Pegvisomant in acromegaly: an update.

Corticotropin releasing hormone: a diagnostic marker for behavioral and reproductive disorders?

Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study

Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-kappaB.

Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression

Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism

Defective hypothalamic growth hormone (GH)-releasing hormone activity may contribute to declining GH secretion with age in man.

Deletion of exons 1–3 of the MEN1 gene in a large Italian family causes the loss of menin expression

Dermorphin decreases plasma LH levels in human: Evidence for a modulatory role of gonadal steroids

Dermorphin inhibits spinal nociceptive flexion reflex in humans

Different levels of thyroglobulin mRNA in normal and neoplastic human thyroids

Differential effects of deltorphin on arginine and galanin-induced growth hormone secretion in healthy man

Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro.

Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women.

Effect of deltorphin on behavior and hippocampal electrical activity in rabbits

Effect of dermorphin on behavior and hippocampal electrical activity in rabbits.

Effect of everolimus on cell viability in nonfunctioning pituitary adenomas.

Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy.

Efficacy and safety of the new 60-mg formulation of the long-acting somatostatin analog lanreotide in the treatment of acromegaly

Efficacy of a slow-release formulation of lanreotide (Autogel) 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study

Evaluation of hormonal function in a series of incidentally discovered adrenal masses.

Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids.

Evidence for Differential Effects of Selective Somatostatin Receptor Subtype Agonists on α-Subunit and Chromogranin A Secretion and on Cell Viability in Human Nonfunctioning Pituitary Adenomasin Vitro

Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation

Evidence that enhancement of cholinergic tone increases basal plasma levels of calcitonin gene-related peptide in normal man

Expression of functional KISS1 and KISS1R system is altered in human pituitary adenomas: evidence for apoptotic action of kisspeptin-10

Growth hormone excess promotes breast cancer chemoresistance

Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression

Growth hormone values after an oral glucose load do not add clinically useful information in patients with acromegaly on long-term somatostatin receptor ligand treatment

High prevalence of differentiated thyroid carcinoma in acromegaly

High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial.

Hormonal replacement therapy affects calcitonin gene-related peptide and atrial natriuretic peptide secretion in postmenopausal women.

Hypopituitarism after traumatic brain injury

Identification of a c-myc oncogene lacking the exon 1 in the normal cells of a patient carrying a thyroid carcinoma

Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas

In vitro effects of estrogen on tgb and c-myc gene expression in normal and neoplastic human thyroids

In vitro testing of new somatostatin analogs on pituitary tumor cells

Inhibitory effects of mitotane on viability and secretory activity in mouse gonadotroph cell lines

Interrelationships between calcitonin gene-related peptide and sympathoadrenomedullary system: Effects of administration of epinephrine and norepinephrine in healthy man

Isolated R171Q amino acid change in MEN1 gene: polymorphism or mutation?

Magmas, a gene newly identified as overexpressed in human and mouse ACTH-secreting pituitary adenomas, protects pituitary cells from apoptotic stimuli

Maternal plasma calcitonin gene–related peptide levels do not change during labor and are not influenced by delivery route

MicroRNAs and possible role in pituitary adenoma.

Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells

Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function

Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes

Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes

N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis

Occurrence of pituitary dysfunction following traumatic brain injury

Ovarian tumors secreting insulin

Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion

Pegvisomant in acromegaly: an update

Pegvisomant in acromegaly: why, when, how.

Pitfalls in scintigraphic detection of neuroendocrine tumours

Pituitary side effects of old and new drugs

Plasma galanin response to head-up tilt in normal subjects and patients with recurrent vasovagal syncope

Predictive value of circulating insulin-like growth factor I levels in ischemic stroke outcome

Predictors of pituitary dysfunction in patients surviving ischemic stroke

Primary empty sella: Why and when to investigate hypothalamic-pituitary function

Prognostic Significance of the Ki-67 Labeling Index in Growth Hormone-Secreting Pituitary Adenomas